ERBB2 and invasive breast carcinoma: An additional analysis of the transcriptomic data of breast invasive carcinoma (BRCA) from The Cancer Genome Atlas Program (TCGA) using the UALCAN tool [34,35] showed a statistically significant lower expression of RBMS 3 in both the HER-2-enriched and TNBC subtypes of breast cancer.